Medical Device Network on MSN

Boston Scientific touts long-term data of SCS therapy

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Nasdaq

Boston Scientific's (BSX) Wavewriter Alpha SCS Gets FDA's Nod

Boston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. With this approval, the system will be available ...